Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 15/20 | 0.54 |
| ▸ | CACNA1B | Q00975 | 3/20 | 0.53 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 3/20 | 0.51 |
| ▸ | RAD52 | P43351 | 1/20 | 0.51 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5794565 | 1.00 | HRH3 (0.54) | HRH3CACNA1BCACNA1HACHERAD52 | |
| SCHEMBL5794567 | 1.00 | HRH3 (0.54) | HRH3CACNA1BCACNA1HACHERAD52 | |
| SCHEMBL5908074 | 0.94 | HRH3 (0.53) | HRH3ACHERAD52 | |
| SCHEMBL5908076 | 0.94 | HRH3 (0.53) | HRH3ACHERAD52 | |
| SCHEMBL5908077 | 0.94 | HRH3 (0.53) | HRH3ACHERAD52 | |
| SCHEMBL5792968 | 0.90 | HRH3 (0.57) | HRH3CACNA1BACHERAD52 | |
| SCHEMBL5792971 | 0.90 | HRH3 (0.57) | HRH3CACNA1BACHERAD52 | |
| SCHEMBL5792965 | 0.90 | HRH3 (0.57) | HRH3CACNA1BACHERAD52 | |
| SCHEMBL5796896 | 0.86 | HRH3 (0.55) | HRH3ACHERAD52 | |
| SCHEMBL5796894 | 0.86 | HRH3 (0.55) | HRH3ACHERAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060047114-A1 | Azabicyclic amine histamine-3 receptor antagonists | PFIZER INC | 2006-03-02 | — | — | US | claimed |
| WO-2006024955-A1 | AZABICYCLIC AMINE HISTAMINE-3 RECEPTOR ANTAGONISTS | PFIZER PRODUCTS INC. (US) | 2006-03-09 | — | — | WO | disclosed |
| US-20060047114-A1 | Azabicyclic amine histamine-3 receptor antagonists | PFIZER INC | 2006-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060047114-A1 | Azabicyclic amine histamine-3 receptor antagonists | HRH3, HRH4, HRH2 | HRH3 1/4885CACNA1B 2789/4885CACNA1H 3064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.